Sunflower Pharmaceuticals Group Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 22.45%

Sunflower Pharmaceuticals Group Co Ltd (002737) has an Asset Resilience Ratio of 22.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Sunflower Pharmaceuticals Group Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.20 Billion

≈ $175.97 Million USD Cash + Short-term Investments

Total Assets

CN¥5.36 Billion

≈ $783.70 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Sunflower Pharmaceuticals Group Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 002737 total assets.

Liquid Assets Composition Over Time

This chart breaks down Sunflower Pharmaceuticals Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 002737 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.20 Billion	22.45%
Total Liquid Assets	CN¥1.20 Billion	22.45%

Asset Resilience Insights

Good Liquidity Position: Sunflower Pharmaceuticals Group Co Ltd maintains a healthy 22.45% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Sunflower Pharmaceuticals Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Sunflower Pharmaceuticals Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Sunflower Pharmaceuticals Group Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Sunflower Pharmaceuticals Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	32.94%	CN¥1.76 Billion ≈ $256.85 Million	CN¥5.33 Billion ≈ $779.70 Million	+11.34pp
2024-12-31	21.60%	CN¥1.26 Billion ≈ $184.12 Million	CN¥5.83 Billion ≈ $852.51 Million	+2.49pp
2023-12-31	19.11%	CN¥1.32 Billion ≈ $192.44 Million	CN¥6.88 Billion ≈ $1.01 Billion	-1.49pp
2022-12-31	20.60%	CN¥1.45 Billion ≈ $211.99 Million	CN¥7.03 Billion ≈ $1.03 Billion	+8.74pp
2021-12-31	11.87%	CN¥668.69 Million ≈ $97.85 Million	CN¥5.64 Billion ≈ $824.61 Million	+8.92pp
2020-12-31	2.94%	CN¥150.49 Million ≈ $22.02 Million	CN¥5.11 Billion ≈ $748.24 Million	-0.92pp
2019-12-31	3.86%	CN¥205.00 Million ≈ $30.00 Million	CN¥5.31 Billion ≈ $776.92 Million	-0.95pp
2018-12-31	4.81%	CN¥243.46 Million ≈ $35.63 Million	CN¥5.06 Billion ≈ $740.31 Million	-0.87pp
2017-12-31	5.68%	CN¥254.00 Million ≈ $37.17 Million	CN¥4.47 Billion ≈ $654.13 Million	-0.43pp
2016-12-31	6.11%	CN¥258.00 Million ≈ $37.75 Million	CN¥4.22 Billion ≈ $618.05 Million	--

pp = percentage points

About Sunflower Pharmaceuticals Group Co Ltd

SHE:002737 China Drug Manufacturers - Specialty & Generic

Market Cap

$961.40 Million

CN¥6.57 Billion CNY

Market Cap Rank

#9141 Global

#2269 in China

Share Price

CN¥11.25

Change (1 day)

+0.27%

52-Week Range

CN¥11.21 - CN¥15.62

All Time High

CN¥28.79